European consensus conference on faecal microbiota transplantation in clinical practice

Show full item record



Permalink

http://hdl.handle.net/10138/178241

Citation

Cammarota , G , Ianiro , G , Tilg , H , Rajilic-Stojanovic , M , Kump , P , Satokari , R , Sokol , H , Arkkila , P , Pintus , C , Hart , A , Segal , J , Aloi , M , Masucci , L , Molinaro , A , Scaldaferri , F , Gasbarrini , G , Lopez-Sanroman , A , Link , A , De Groot , P , de Vos , W M , Hoegenauer , C , Malfertheiner , P , Mattila , E , Milosavljevic , T , Nieuwdorp , M , Sanguinetti , M , Simren , M , Gasbarrini , A & European FMT Working Grp 2017 , ' European consensus conference on faecal microbiota transplantation in clinical practice ' , Gut , vol. 66 , no. 4 , pp. 569-580 . https://doi.org/10.1136/gutjnl-2016-313017

Title: European consensus conference on faecal microbiota transplantation in clinical practice
Author: Cammarota, Giovanni; Ianiro, Gianluca; Tilg, Herbert; Rajilic-Stojanovic, Mirjana; Kump, Patrizia; Satokari, Reetta; Sokol, Harry; Arkkila, Perttu; Pintus, Cristina; Hart, Ailsa; Segal, Jonathan; Aloi, Marina; Masucci, Luca; Molinaro, Antonio; Scaldaferri, Franco; Gasbarrini, Giovanni; Lopez-Sanroman, Antonio; Link, Alexander; De Groot, Pieter; de Vos, Willem M.; Hoegenauer, Christoph; Malfertheiner, Peter; Mattila, Eero; Milosavljevic, Tomica; Nieuwdorp, Max; Sanguinetti, Maurizio; Simren, Magnus; Gasbarrini, Antonio; European FMT Working Grp
Other contributor: University of Helsinki, Research Programs Unit
University of Helsinki, Department of Medicine
University of Helsinki, Medicum
University of Helsinki, Department of Medicine












Date: 2017-04
Language: eng
Number of pages: 12
Belongs to series: Gut
ISSN: 0017-5749
DOI: https://doi.org/10.1136/gutjnl-2016-313017
URI: http://hdl.handle.net/10138/178241
Abstract: Faecal microbiota transplantation (FMT) is an important therapeutic option for Clostridium difficile infection. Promising findings suggest that FMT may play a role also in the management of other disorders associated with the alteration of gut microbiota. Although the health community is assessing FMT with renewed interest and patients are becoming more aware, there are technical and logistical issues in establishing such a non-standardised treatment into the clinical practice with safety and proper governance. In view of this, an evidence-based recommendation is needed to drive the practical implementation of FMT. In this European Consensus Conference, 28 experts from 10 countries collaborated, in separate working groups and through an evidence-based process, to provide statements on the following key issues: FMT indications; donor selection; preparation of faecal material; clinical management and faecal delivery and basic requirements for implementing an FMT centre. Statements developed by each working group were evaluated and voted by all members, first through an electronic Delphi process, and then in a plenary consensus conference. The recommendations were released according to best available evidence, in order to act as guidance for physicians who plan to implement FMT, aiming at supporting the broad availability of the procedure, discussing other issues relevant to FMT and promoting future clinical research in the area of gut microbiota manipulation. This consensus report strongly recommends the implementation of FMT centres for the treatment of C. difficile infection as well as traces the guidelines of technicality, regulatory, administrative and laboratory requirements.
Subject: CLOSTRIDIUM-DIFFICILE INFECTION
TERM-FOLLOW-UP
RANDOMIZED CONTROLLED-TRIAL
ACTIVE ULCERATIVE-COLITIS
IRRITABLE-BOWEL-SYNDROME
INTESTINAL MICROBIOTA
NASOGASTRIC TUBE
FROZEN INOCULUM
RECURRENT
DISEASE
3121 General medicine, internal medicine and other clinical medicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
European_consensus_conference_on_faecal.pdf 708.5Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record